| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.47 | 0.03 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.46 | 0.03 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.29 | 0.4 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.17 | 0.4 |